No black box warning on record for Binosto

As of the latest FDA labeling reviewed, Binosto (ALENDRONATE SODIUM) does not carry a black box warning. Standard warnings and precautions still apply — see the full Binosto medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Upper Gastrointestinal Adverse Reactions can occur. Instruct patients to follow dosing instructions. Discontinue if new or worsening symptoms occur. ( 5.1 ) Hypocalcemia can worsen and must be corrected prior to use. ( 5.2 ) Severe Bone, Joint, Muscle Pain may occur. Discontinue use if severe symptoms develop. ( 5.3 ) Osteonecrosis of the Jaw has been reported. ( 5.4 ) A

No black box warning on record for Binosto

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Upper Gastrointestinal Adverse Reactions can occur. Instruct patients to follow dosing instructions. Discontinue if new or worsening symptoms occur. ( 5.1 ) Hypocalcemia can worsen and must be corrected prior to use. ( 5.2 ) Severe Bone, Joint, Muscle Pain may occur. Discontinue use if severe symptoms develop. ( 5.3 ) Osteonecrosis of the Jaw has been reported. ( 5.4 ) A

Binosto Black Box Warning

No black box warning on record for Binosto

Other warnings & precautions

Binosto Black Box Warning

No black box warning on record for Binosto

Other warnings & precautions